131 related articles for article (PubMed ID: 4607675)
1. [Double blind clinical experiences with L.S. 121 (praxilene) in patients with chronic ischemic peripheral syndromes].
Bianchi G
Minerva Chir; 1974 Aug; 29(15-16):885-90. PubMed ID: 4607675
[No Abstract] [Full Text] [Related]
2. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
Longo FN; Potortì F; Urbano O; Perroni GB
Minerva Cardioangiol; 1988 May; 36(5):249-52. PubMed ID: 3059229
[No Abstract] [Full Text] [Related]
3. [Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
Gregoratti L; Redaelli G; Limido P; Ghiringhelli L
Clin Ter; 1982 Sep; 102(6):607-19. PubMed ID: 6291844
[No Abstract] [Full Text] [Related]
4. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
Horsch S; Claeys L
Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
[No Abstract] [Full Text] [Related]
5. [Treatment with piribedil in peripheral arterial diseases].
Gatta L; Corti G; Bernasconi S
Minerva Med; 1976 May; 67(25):1668-70. PubMed ID: 778669
[No Abstract] [Full Text] [Related]
6. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
7. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
Trübestein G; Trübestein R; Ludwig M
Fortschr Med; 1989 Dec; 107(36):781-4. PubMed ID: 2695437
[TBL] [Abstract][Full Text] [Related]
8. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
Ionescu G; Pitea P; Blaj A
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
[No Abstract] [Full Text] [Related]
9. [Action of nitrates on pressure and volume in the peripheral circulation of patients with coronary heart disease and with peripheral arterial occlusive diseases].
Caesar K; Niemeyer H; Hossmann V; Saborowski F
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1738-41. PubMed ID: 347799
[No Abstract] [Full Text] [Related]
10. [Experiences with ultra-high dosage fibrinolysis in arterial occlusive disease].
Redecker M; Heinrich F; Fenn K
Vasa Suppl; 1988; 23():182-5. PubMed ID: 3206334
[No Abstract] [Full Text] [Related]
11. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
Musil HE
Med Welt; 1973 Jan; 24(3):103-13. PubMed ID: 4617835
[No Abstract] [Full Text] [Related]
12. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
Vaccaro E; Solitro A; Barba C
Arzneimittelforschung; 1973 Dec; 23(12):1793-8. PubMed ID: 4205907
[No Abstract] [Full Text] [Related]
13. [Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication].
Horsch S; Claeys L; Diehm C; Rieger H; Cachovan M; Baitsch C
Vasa Suppl; 1992; 37():64-5. PubMed ID: 1481105
[No Abstract] [Full Text] [Related]
14. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
König FK
Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
[No Abstract] [Full Text] [Related]
15. Therapeutic effect of ticlopidine for ischemic leg ulcers.
Katsumura T
Agents Actions Suppl; 1984; 15():167-72. PubMed ID: 6385645
[No Abstract] [Full Text] [Related]
16. Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of Angiology.
Heidrich H; Allenberg J; Cachovan M; Creutzig A; Diehm C; Gruss J; Kriessmann A; Rieger H; Rudofsky G; Trampisch HJ
Vasa; 1992; 21(4):333-43. PubMed ID: 1485465
[No Abstract] [Full Text] [Related]
17. [Evaluation of the effects on the peripheral blood circulation of i.v. administration of high doses of phosphocreatinine in patients with arterial diseases].
de Divitiis O; Abate S; Di Somma S; Ferulano GP; Petitto M; Vanni L; Villari B; Di Lillo S; Fazio S; Picilli M
Minerva Cardioangiol; 1986 Oct; 34(10):671-80. PubMed ID: 2949160
[No Abstract] [Full Text] [Related]
18. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
Ambrosi V; Gabrielli F
Minerva Med; 1983 Mar; 74(13):685-9. PubMed ID: 6220230
[TBL] [Abstract][Full Text] [Related]
19. [Piribedil in arterial diseases].
Cristol R; Arnaud F
Nouv Presse Med; 1974 Nov 30-Dec 14; 3(41-43):2573-4. PubMed ID: 4619431
[No Abstract] [Full Text] [Related]
20. [Determinations of clinical variations and lipid metabolism in patients with chronic ischemia of the lower extremities by means of a pentosan sulfonic ester and xanthinol niacinate combination].
González González M; Azcona Elizalde JM; Lorente Navarro MC; Duato Jane A
Angiologia; 1979; 31(4):180-4. PubMed ID: 382919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
